- Home
- MEDP vs JLL Comparison
MEDP vs JLL Comparison
Compare MEDP & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- JLL
- Stock Information
- Founded
- MEDP 1992
- JLL 1997
- Country
- MEDP United States
- JLL United States
- Employees
- MEDP N/A
- JLL N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- JLL Real Estate
- Sector
- MEDP Health Care
- JLL Finance
- Exchange
- MEDP Nasdaq
- JLL Nasdaq
- Market Cap
- MEDP 13.4B
- JLL 14.1B
- IPO Year
- MEDP 2016
- JLL 1997
- Fundamental
- Price
- MEDP $585.14
- JLL $292.48
- Analyst Decision
- MEDP Hold
- JLL Buy
- Analyst Count
- MEDP 12
- JLL 8
- Target Price
- MEDP $465.18
- JLL $338.29
- AVG Volume (30 Days)
- MEDP 324.1K
- JLL 312.5K
- Earning Date
- MEDP 10-22-2025
- JLL 11-05-2025
- Dividend Yield
- MEDP N/A
- JLL N/A
- EPS Growth
- MEDP 25.36
- JLL 31.91
- EPS
- MEDP 14.32
- JLL 13.05
- Revenue
- MEDP $2,358,373,000.00
- JLL $25,317,800,000.00
- Revenue This Year
- MEDP $21.48
- JLL $12.21
- Revenue Next Year
- MEDP $11.90
- JLL $8.43
- P/E Ratio
- MEDP $40.91
- JLL $23.19
- Revenue Growth
- MEDP 13.88
- JLL 12.51
- 52 Week Low
- MEDP $250.05
- JLL $194.36
- 52 Week High
- MEDP $625.00
- JLL $322.37
- Technical
- Relative Strength Index (RSI)
- MEDP 57.97
- JLL 42.82
- Support Level
- MEDP $573.07
- JLL $286.92
- Resistance Level
- MEDP $609.13
- JLL $310.38
- Average True Range (ATR)
- MEDP 16.64
- JLL 9.84
- MACD
- MEDP -3.57
- JLL -0.56
- Stochastic Oscillator
- MEDP 38.72
- JLL 48.22
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.